Jun Gong: Podcast on mUC and how maintenance avelumab fits into the global 1L paradigm

Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared a post on X by EMD Serono adding:

“Was a delight doing this podcast with Melissa Reimers, Siteman Cancer Center and Washington University in St. Louis on mUC and how maintenance avelumab fits into the global 1L paradigm.

Published in: Springer Nature and Advances in Therapy.”

Quoting EMD Serono’s post below:

“Listen to two medical oncologists, Jun Gong and Melissa Reimers, as they provide their practical considerations in first-line treatments of patients with advanced urothelial carcinoma in this podcast.”

View the article attached to the post.
Sources: Jun Gong/X and EMD Serono/X